Genitourinary Cancer,RCC (Renal Cell Carcinoma) Belzutifan Shows PFS Benefits Over Everolimus in ccRCC Sep 17, 2024
Bladder Cancer,Genitourinary Cancer Exploring LIG1 Role in BLCA Progression and Prognosis Sep 09, 2024
Bladder Cancer,Genitourinary Cancer YAP1 Downregulation Impacts YTHDF3 and SMAD7 in BCSCs Sep 05, 2024
Bladder Cancer,Genitourinary Cancer KRT23 Identified as Key Target in BLCA Immunotherapy Sep 05, 2024
Bladder Cancer,Genitourinary Cancer,RCC (Renal Cell Carcinoma) Impact of QoL and Optimism on Prognostic Views in mRCC and mBC Sep 05, 2024
Bladder Cancer,Genitourinary Cancer Low HALP Scores Predict Bladder Cancer Recurrence After UTUC Sep 04, 2024
